Skip to contentH
Haemonetics Corp
H
HAEHaemonetics Corp Q1 2023 · 10-Q
Revenue$261.46M$261.46M+14.4% vs Q1 2022 Net Income$19.88M$19.88MN/M vs Q1 2022 EPS Diluted$0.38$0.38N/M vs Q1 2022 Gross Profit$142,263,000+31.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
Operating Cash Flow$41,993,000N/M Free Cash Flowderived-$3,474,000N/M Margins · derivedGross margin54.4%+7.1 pt vs Q1 2022
Operating margin11.8%+11.2 pt vs Q1 2022
Net margin7.6%+9.6 pt vs Q1 2022
ended Jul 2, 2022 · filed Aug 10, 2022 · 39 d after period end